REVLI MID® (lenalido mide) is a prescription medicine, used to treat adults with multiple myeloma (MM) in combination with the medicine dexamethasone, or as maintenance treatment after autologous hematopoietic stem transplantation (a type of stem transplant that uses your own stem ). REVLI MID should not be used to treat people who have chronic lymcytic leukemia (CLL) unless they are participants in a controlled clinical trial. It is not known if REVLI MID is safe and effective in children.
我们了解更多详情：
立即注册即可享受折扣。 在为时已晚之前开始吧！
